Radiopharmaceutical therapy is exposing a broader challenge for clinical development: scientific innovation can advance only ...
The FDA has published a Transparency Roadmap outlining its fiscal year 2026 milestones and fiscal year 2027 priorities across ...
In today's ACT Brief, we examine FDA input sought on early-phase ibogaine protocols, why mixed outsourcing models spread ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results